Green Valley Investors Llc decreased its stake in Mednax Inc (MD) by 19.69% based on its latest 2018Q1 regulatory filing with the SEC. Green Valley Investors Llc sold 80,100 shares as the company’s stock declined 15.90% with the market. The institutional investor held 326,754 shares of the health care company at the end of 2018Q1, valued at $18.18M, down from 406,854 at the end of the previous reported quarter. Green Valley Investors Llc who had been investing in Mednax Inc for a number of months, seems to be less bullish one the $4.15 billion market cap company. The stock decreased 1.14% or $0.51 during the last trading session, reaching $44.35. About 1.86 million shares traded or 140.99% up from the average. MEDNAX, Inc. (NYSE:MD) has declined 15.55% since June 17, 2017 and is downtrending. It has underperformed by 28.12% the S&P500. Some Historical MD News: 26/04/2018 – KYNIKOS’S JIM CHANOS SAYS HE IS SHORT MEDNAX INC – CNBC; 01/05/2018 – MEDNAX EXECUTIVE MAKES COMMENT ON EARNINGS CONFERENCE CALL; 24/04/2018 – MEDNAX REPORTS PURCHASE OF LEADING TEXAS RADIOLOGY PRACTICE; 07/05/2018 – ATRIUM HEALTH AMENDS COUNTERSUIT TO MEDNAX DUE TO CONTINUED FAL; 10/04/2018 – MedData’s New Patient Financial Platform Solves Inefficient, Costly Revenue Cycle Challenges; 11/05/2018 – Statement from Southeast Anesthesiology Consultants and Mednax Services, Inc; 30/04/2018 – Mednax Sees 2Q EPS 81c-EPS 86c; 02/04/2018 – MEDNAX REPORTS PURCHASE OF PEDIATRIC UROLOGY PRACTICE IN SOUTH; 21/03/2018 – MEDNAX INC – ANNOUNCED ACQUISITION OF CHILDREN’S EYE CARE, LLC, A PRIVATE PEDIATRIC OPHTHALMOLOGY PRACTICE; 16/05/2018 – Mednax Presenting at Bank of America Conference Tomorrow
Clifton S. Robbins decreased its stake in Allscripts Healthcare Solutn (MDRX) by 50% based on its latest 2018Q1 regulatory filing with the SEC. Blue Harbour Group Lp sold 200,000 shares as the company’s stock declined 7.90% with the market. The hedge fund run by Clifton S. Robbins held 200,000 shares of the technology company at the end of 2018Q1, valued at $2.47 million, down from 400,000 at the end of the previous reported quarter. Blue Harbour Group Lp who had been investing in Allscripts Healthcare Solutn for a number of months, seems to be less bullish one the $2.24 billion market cap company. The stock increased 1.29% or $0.16 during the last trading session, reaching $12.59. About 2.28M shares traded or 20.60% up from the average. Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) has risen 10.53% since June 17, 2017 and is uptrending. It has underperformed by 2.04% the S&P500. Some Historical MDRX News: 08/03/2018 – MOODY’S AFFIRMS HYLAND’S B2 CFR AFTER DEBT-FUNDED ACQUISITION; 03/05/2018 – ALLSCRIPTS TO ACQUIRE HEALTHGRID; 03/05/2018 – Allscripts Backs 2018 Rev $2.15B-$2.25B; 03/05/2018 – Allscripts 1Q Cont Ops Loss/Shr 25c; 08/03/2018 – ALLSCRIPTS TO RETAIN ENTIRETY OF SINGAPORE SUNRISE CLIENT BASE; 02/04/2018 – Hyland completes acquisition of OneContent from Allscripts; 03/05/2018 – MDRX TO BUY HEALTHGRID FOR $60M IN CASH, MAX. $50M IN EARNOUTS; 06/03/2018 – Allscripts launches industry’s first machine learning EHR; 05/04/2018 – ALLSCRIPTS HEALTHCARE SOLUTIONS INC – PURCHASE PRICE FOR ACQUISITION WILL BE FUNDED WITH BORROWINGS UNDER NETSMART’S EXISTING CREDIT FACILITIES; 24/05/2018 – ALLSCRIPTS SAYS HEALTHCARE GROUP SINGHEALTH HAS PARTNERED WITH ALLSCRIPTS TO IMPLEMENT IPRO ANESTHESIA ACROSS THE GROUP
Since March 14, 2018, it had 1 buying transaction, and 2 selling transactions for $221,456 activity. KLAYKO MICHAEL bought 4,000 shares worth $50,080. Farley Brian had sold 5,000 shares worth $68,629.
Blue Harbour Group Lp, which manages about $2.20 billion and $2.88 billion US Long portfolio, upped its stake in Mednax Inc (NYSE:MD) by 397,600 shares to 4.51M shares, valued at $250.83 million in 2018Q1, according to the filing. It also increased its holding in Open Text Corp (NASDAQ:OTEX) by 461,923 shares in the quarter, for a total of 9.79 million shares, and has risen its stake in On Semiconductor Corp (ONNN).
Analysts await Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) to report earnings on August, 2. They expect $0.13 EPS, up 18.18% or $0.02 from last year’s $0.11 per share. MDRX’s profit will be $23.13 million for 24.21 P/E if the $0.13 EPS becomes a reality. After $0.11 actual EPS reported by Allscripts Healthcare Solutions, Inc. for the previous quarter, Wall Street now forecasts 18.18% EPS growth.
Investors sentiment increased to 1.07 in 2018 Q1. Its up 0.09, from 0.98 in 2017Q4. It increased, as 16 investors sold MDRX shares while 81 reduced holdings. 39 funds opened positions while 65 raised stakes. 182.67 million shares or 2.41% less from 187.17 million shares in 2017Q4 were reported. 122,351 were reported by Arizona State Retirement. Numerixs Inv Technologies has invested 0.05% in Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX). Moreover, Menta Capital Limited Liability Corporation has 0.59% invested in Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX). Iridian Asset Management Limited Liability Ct invested in 0.79% or 7.15 million shares. 35,206 are held by Koch Indus Inc. Geode Capital Mgmt Ltd holds 0.01% or 1.94 million shares in its portfolio. New York-based D E Shaw Communication has invested 0.05% in Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX). Rhumbline Advisers has 351,783 shares for 0.01% of their portfolio. 561 were reported by Northwestern Mutual Wealth Mgmt Com. Laurion Capital Mgmt LP reported 34,150 shares or 0% of all its holdings. Rmb Cap Management Lc accumulated 81,157 shares. Goldman Sachs Grp Inc holds 0.02% in Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) or 7.66M shares. North Star Asset accumulated 0.68% or 613,593 shares. Gsa Cap Prtn Limited Liability Partnership holds 0.03% of its portfolio in Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) for 47,903 shares. Comml Bank Of New York Mellon Corp owns 2.60 million shares or 0.01% of their US portfolio.
Among 27 analysts covering Allscripts-Misys Healthcare (NASDAQ:MDRX), 15 have Buy rating, 1 Sell and 11 Hold. Therefore 56% are positive. Allscripts-Misys Healthcare had 73 analyst reports since August 5, 2015 according to SRatingsIntel. The company was upgraded on Monday, August 24 by Argus Research. Topeka Capital Markets maintained Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) rating on Tuesday, January 5. Topeka Capital Markets has “Hold” rating and $15.0 target. The firm has “Buy” rating given on Friday, August 4 by Maxim Group. The stock has “Buy” rating by Maxim Group on Tuesday, January 10. The rating was upgraded by Cowen & Co to “Outperform” on Monday, September 11. The rating was maintained by Canaccord Genuity on Friday, February 16 with “Buy”. Cantor Fitzgerald maintained Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) on Tuesday, March 6 with “Buy” rating. The stock of Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) earned “Buy” rating by Jefferies on Friday, October 16. On Sunday, October 29 the stock rating was maintained by RBC Capital Markets with “Buy”. Canaccord Genuity initiated Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) on Wednesday, September 16 with “Buy” rating.
More important recent Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) news were published by: Nasdaq.com which released: “HealthGrid CEO awarded Ernst & Young’s Entrepreneur of the Year for Florida Region” on June 12, 2018, also Nasdaq.com published article titled: “Allscripts to present at Baird’s 2018 Global Consumer, Technology & Services Conference”, Globenewswire.com published: “Allscripts to deliver anesthesia solution across SingHealth healthcare institutions” on May 24, 2018. More interesting news about Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) was released by: Globenewswire.com and their article: “Allscripts closes acquisition of HealthGrid” with publication date: May 21, 2018.
Analysts await MEDNAX, Inc. (NYSE:MD) to report earnings on July, 27. They expect $1.00 EPS, up 25.00% or $0.20 from last year’s $0.8 per share. MD’s profit will be $93.46M for 11.09 P/E if the $1.00 EPS becomes a reality. After $0.81 actual EPS reported by MEDNAX, Inc. for the previous quarter, Wall Street now forecasts 23.46% EPS growth.
More news for MEDNAX, Inc. (NYSE:MD) were recently published by: Businesswire.com, which released: “MEDNAX to Present at the Jefferies 2018 Global Healthcare Conference” on June 01, 2018. Businesswire.com‘s article titled: “MEDNAX National Medical Group and Pacira Pharmaceuticals Launch National Enhanced Recovery after Cesarean …” and published on June 13, 2018 is yet another important article.